This article is over 8 years old


Texans Offensive Lineman Fighting Cancer

Houston Texans offensive lineman David Quessenberry has been diagnosed with non-Hodgkins Lymphoma and will likely miss the upcoming season. He’s already started treatment at MD Anderson Cancer Center in Houston.


To embed this piece of audio in your site, please use this code:

<iframe src="" style="height: 115px; width: 100%;"></iframe>

A Houston Texans offensive lineman has been diagnosed with lymphoma and has already started what will likely be a lengthy treatment plan.

David Quessenberry, 23, had been experiencing symptoms of a chest cold, with coughing and fatigue. When doctors checked him out last week, they diagnosed him with non-Hodgkins T Lymphoblastic Lymphoma.

He has already started chemotherapy treatment at MD Anderson Cancer Center.

“The most classical signs and symptoms of the disease are an enlarging mass arising from your lymph nodes,” said Dr. Gustavo Rivero, a professor of hematology and oncology at Baylor College of Medicine.

T-type lymphoma is more aggressive, with a five year survival rate of around 30 percent. But, with targeted therapies, the survival rate can be much higher.

“We have been able to achieve a much better understanding of these tumors by doing genomic studies of the tumor types,” he said. “We have perfected those therapies and we have been able to improve survival in those patients.”

The Texans have placed Quessenberry on the NFL’s non-football illness list and he’s likely to miss the upcoming season.

On Twitter, Quessenberry has said he plans to beat the disease and get back to football as soon as he can.

Subscribe to Today in Houston

Fill out the form below to subscribe our new daily editorial newsletter from the HPM Newsroom.

* required